share_log
Benzinga ·  2024/05/24 21:48

Vanda Pharmaceuticals Rejects Revised Unsolicited Acquisition Proposal From Future Pak, Concluding It Undervalues The Company; Board Unanimously Decides Proposal Is Not In The Best Interests Of Shareholders

Vanda Pharmicals拒絕了Future Pak主動提出的經修訂的收購提案,認爲該提案低估了公司的價值;董事會一致認爲該提案不符合股東的最大利益

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論